We are pleased to announce that Sickle Cell in Focus (SCiF) will take place in 2021 for the 14th annual conference on September 30 & October 1, 2021. The SCiF conference will once again be co-hosted by the National Heart, Lung, and Blood Institute and the University of West Indies (Jamaica). Due to current travel restrictions, this year’s conference will be held virtual via Zoom.
SCiF is a two-day, intensive, educational update on sickle cell disease. We aim to provide consultants, trainees, doctors, healthcare professionals, and academics interested in hemoglobin disorders with an opportunity for a comprehensive and global exploration of the current medical trends and research results in sickle cell disease. SCiF 2021 will highlight emerging clinical and management issues relating to sickle cell disease, emerging therapies and how we can use them in combination for effective treatment, and in light of the recent pandemic, we will also have a session on the impact of COVID-19 on patients with sickle cell disease. Each day will convene with a panel discussion; the first on FDA approved drugs and the second on the issue of gene therapy vs bone marrow transplant.